ArticleAmerican journal of cancer research2023

T790M detection rate after first-line combination therapy with bevacizumab and EGFR-TKIs in advanced NSCLC (TERRA Study).

Chih-Hsi Scott Kuo et al.PubMed ↗Full text ↗

No numbers read from the abstract.